Role of clipping in aneurysmal subarachnoid hemorrhage: a post hoc analysis of the Earlydrain trial.


Journal

Neurosurgical review
ISSN: 1437-2320
Titre abrégé: Neurosurg Rev
Pays: Germany
ID NLM: 7908181

Informations de publication

Date de publication:
26 Oct 2024
Historique:
received: 01 08 2024
accepted: 13 10 2024
revised: 05 10 2024
medline: 26 10 2024
pubmed: 26 10 2024
entrez: 25 10 2024
Statut: epublish

Résumé

The choice between clipping and coiling of ruptured cerebral aneurysms in subarachnoid hemorrhage (SAH) remains controversial. The recently published Earlydrain trial provides the opportunity to analyze the latest clip-to-coil ratio in German-speaking countries and to evaluate vasospasm incidence and explorative outcome measures in both treatment modalities. We performed a post hoc analysis of the Earlydrain trial, a multicenter randomized controlled trial investigating the use of an additional lumbar drain in aneurysmal SAH. The decision whether to clip or to coil the ruptured aneurysm was left to the discretion of the participating centers, providing a real-world insight into current aneurysm treatment strategies. Earlydrain was performed in 19 centers in Germany, Switzerland, and Canada, recruiting 287 patients with aneurysmal SAH of all severity grades. Of these, 140 patients (49%) received clipping and 147 patients (51%) coiling. Age and clinical severity based on Hunt-Hess/WFNS grades and radiological criteria were similar. Clipping was more frequently used for anterior circulation aneurysms (55%), whereas posterior circulation aneurysms were mostly coiled (86%, p < 0.001). In high-volume recruiting centers, 56% of patients were treated with clipping, compared to 38% in other centers. A per-year analysis showed a stable and balanced clipping/coiling ratio over time. Regarding vasospasm, 60% of clipped versus 43% of coiled patients showed elevated transcranial Doppler criteria (p = 0.007), reflected in angiographic vasospasm rates (51% vs. 38%, p = 0.03). In contrast to the Earlydrain main results establishing the superiority of an additional lumbar drain, explorative outcomes after clipping and coiling measured by secondary infarctions, mortality, modified Rankin Score, Glasgow Outcome Scale Extended, or Barthel-Index showed no significant differences after discharge and at six months. In clinical practice, aneurysm clipping is still a frequently used method in aneurysmal SAH. Apart from a higher rate of vasospasm in the clipping group, an exploratory outcome analysis showed no difference between the two treatment methods. Further development of periprocedural treatment modalities for clipped ruptured aneurysms to reduce vasospasm is warranted.

Identifiants

pubmed: 39455468
doi: 10.1007/s10143-024-03057-w
pii: 10.1007/s10143-024-03057-w
doi:

Types de publication

Journal Article Multicenter Study Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

824

Informations de copyright

© 2024. The Author(s).

Références

Ikawa F et al (Apr.2020) In-hospital mortality and poor outcome after surgical clipping and endovascular coiling for aneurysmal subarachnoid hemorrhage using nationwide databases: a systematic review and meta-analysis. Neurosurg Rev 43(2):655–667. https://doi.org/10.1007/s10143-019-01096-2
doi: 10.1007/s10143-019-01096-2 pubmed: 30941595
Lindgren A et al (2018) Endovascular coiling versus neurosurgical clipping for people with aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev 8(8):CD003085. https://doi.org/10.1002/14651858.CD003085.pub3
doi: 10.1002/14651858.CD003085.pub3 pubmed: 30110521
Neifert SN et al (Jun.2021) Aneurysmal Subarachnoid Hemorrhage: the Last Decade. Transl Stroke Res 12(3):428–446. https://doi.org/10.1007/s12975-020-00867-0
doi: 10.1007/s12975-020-00867-0 pubmed: 33078345
Hostettler IC et al (2023) Duration between aneurysm rupture and treatment and its association with outcome in aneurysmal subarachnoid haemorrhage. Sci Rep 13(1):1527. https://doi.org/10.1038/s41598-022-27177-9
doi: 10.1038/s41598-022-27177-9 pubmed: 36707604 pmcid: 9883503
van Lieshout JH et al (Sep.2022) Development and Internal Validation of the ARISE Prediction Models for Rebleeding After Aneurysmal Subarachnoid Hemorrhage. Neurosurgery 91(3):450–458. https://doi.org/10.1227/neu.0000000000002045
doi: 10.1227/neu.0000000000002045 pubmed: 35881023
Molyneux A et al (Oct.2002) International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised trial. Lancet 360(9342):1267–1274. https://doi.org/10.1016/s0140-6736(02)11314-6
doi: 10.1016/s0140-6736(02)11314-6 pubmed: 12414200
Peng C, Diao YH, Cai SF, Yang XY (2022) Endovascular coiling versus microsurgical clipping for ruptured intracranial aneurysms: a meta-analysis and systematic review. Chin Neurosurg J 8(1):17. https://doi.org/10.1186/s41016-022-00283-3
doi: 10.1186/s41016-022-00283-3 pubmed: 35879784 pmcid: 9310462
Zhu W, Ling X, Petersen JD, Liu J, Xiao A, Huang J (Apr.2022) Clipping versus coiling for aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis of prospective studies. Neurosurg Rev 45(2):1291–1302. https://doi.org/10.1007/s10143-021-01704-0
doi: 10.1007/s10143-021-01704-0 pubmed: 34870768
Weir B (Oct.2020) Vasospasm: does it cause infarction and poor outcome? J Neurosurg 134(3):1006–1011. https://doi.org/10.3171/2020.7.JNS202551
doi: 10.3171/2020.7.JNS202551 pubmed: 33126209
Golnari P et al (Feb.2020) Volumes, outcomes, and complications after surgical versus endovascular treatment of aneurysms in the United States (1993–2015): continued evolution versus steady-state after more than 2 decades of practice. J Neurosurg 134(3):848–861. https://doi.org/10.3171/2019.12.JNS192755
doi: 10.3171/2019.12.JNS192755 pubmed: 32032946
Calvanese F et al (2024) Changes in treatment of intracranial aneurysms during the last decade in a large European neurovascular center. Acta Neurochir 166(1):173. https://doi.org/10.1007/s00701-024-06064-4
doi: 10.1007/s00701-024-06064-4 pubmed: 38594469
Shah VA et al (2022) Regional Variability in the Care and Outcomes of Subarachnoid Hemorrhage Patients in the United States. Front Neurol 13:908609. https://doi.org/10.3389/fneur.2022.908609
doi: 10.3389/fneur.2022.908609 pubmed: 35785364 pmcid: 9243235
Wolf S et al (2023) Effectiveness of Lumbar Cerebrospinal Fluid Drain Among Patients With Aneurysmal Subarachnoid Hemorrhage: A Randomized Clinical Trial. JAMA Neurol 80(8):833–842. https://doi.org/10.1001/jamaneurol.2023.1792
doi: 10.1001/jamaneurol.2023.1792 pubmed: 37330974 pmcid: 10277935
Diringer MN et al (Sep.2011) Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society’s Multidisciplinary Consensus Conference. Neurocrit Care 15(2):211–240. https://doi.org/10.1007/s12028-011-9605-9
doi: 10.1007/s12028-011-9605-9 pubmed: 21773873
Connolly ESJ et al (Jun.2012) Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/american Stroke Association. Stroke 43(6):1711–1737. https://doi.org/10.1161/STR.0b013e3182587839
doi: 10.1161/STR.0b013e3182587839 pubmed: 22556195
Cummings P (May2009) The relative merits of risk ratios and odds ratios. Arch Pediatr Adolesc Med 163(5):438–445. https://doi.org/10.1001/archpediatrics.2009.31
doi: 10.1001/archpediatrics.2009.31 pubmed: 19414690
Früh A, Wolf S, Wasilewski D, Vajkoczy P, Truckenmueller P (Apr.2024) Early Complications and Outcome After Treatment of Ruptured Aneurysms in Patients with Subarachnoid Hemorrhage-A Post Hoc Analysis of the EARLYDRAIN Trial. World Neurosurg 184:e720–e730. https://doi.org/10.1016/j.wneu.2024.02.018
doi: 10.1016/j.wneu.2024.02.018 pubmed: 38340802
Korja M, Lehto H, Juvela S, Kaprio J (Sep.2016) Incidence of subarachnoid hemorrhage is decreasing together with decreasing smoking rates. Neurology 87(11):1118–1123. https://doi.org/10.1212/WNL.0000000000003091
doi: 10.1212/WNL.0000000000003091 pubmed: 27521438 pmcid: 5027805
Salaud C, Hamel O, Riem T, Desal H, Buffenoir K (Feb.2016) Management of aneurysmal subarachnoid haemorrhage with intracerebral hematoma: Is there an indication for coiling first? Study of 44 cases. Interv Neuroradiol 22(1):5–11. https://doi.org/10.1177/1591019915617320
doi: 10.1177/1591019915617320 pubmed: 26634802 pmcid: 4757382
Bsat S et al (Oct.2020) Safety of stent-assisted coiling for the treatment of wide-necked ruptured aneurysm: A systematic literature review and meta-analysis of prevalence. Interv Neuroradiol 26(5):547–556. https://doi.org/10.1177/1591019920945059
doi: 10.1177/1591019920945059 pubmed: 32741229 pmcid: 7645187
Nabizadeh F, Valizadeh P, Balabandian M (Jan.2024) Stent-assistant versus non-stent-assistant coiling for ruptured and unruptured intracranial aneurysms: A meta-analysis and systematic review. World Neurosurg X 21:100243. https://doi.org/10.1016/j.wnsx.2023.100243
doi: 10.1016/j.wnsx.2023.100243 pubmed: 38221954
Mitchell P, Kerr R, Mendelow AD, Molyneux A (Mar.2008) Could late rebleeding overturn the superiority of cranial aneurysm coil embolization over clip ligation seen in the International Subarachnoid Aneurysm Trial? J Neurosurg 108(3):437–442. https://doi.org/10.3171/JNS/2008/108/3/0437
doi: 10.3171/JNS/2008/108/3/0437 pubmed: 18312088
Hulsbergen AFC et al (Dec.2019) Long-Term Durability of Open Surgical versus Endovascular Repair of Intracranial Aneurysms: A Systematic Review and Meta-Analysis. World Neurosurg 132:e820–e833. https://doi.org/10.1016/j.wneu.2019.08.002
doi: 10.1016/j.wneu.2019.08.002 pubmed: 31419590
Molyneux AJ, Birks J, Clarke A, Sneade M, Kerr RSC (Feb.2015) The durability of endovascular coiling versus neurosurgical clipping of ruptured cerebral aneurysms: 18 year follow-up of the UK cohort of the International Subarachnoid Aneurysm Trial (ISAT). Lancet 385(9969):691–697. https://doi.org/10.1016/S0140-6736(14)60975-2
doi: 10.1016/S0140-6736(14)60975-2 pubmed: 25465111 pmcid: 4356153
Spetzler RF et al (Sep.2015) The Barrow Ruptured Aneurysm Trial: 6-year results. J Neurosurg 123(3):609–617. https://doi.org/10.3171/2014.9.JNS141749
doi: 10.3171/2014.9.JNS141749 pubmed: 26115467
Wach J, Vychopen M, Güresir A, Guranda A, Nestler U, Güresir E (2024) A Long-Term Comparative Analysis of Endovascular Coiling and Clipping for Ruptured Cerebral Aneurysms: An Individual Patient-Level Meta-Analysis Assessing Rerupture Rates. J Clin Med 13(6).  https://doi.org/10.3390/jcm13061778
Darsaut TE, Kotowski M, Raymond J (2012) How to choose clipping versus coiling in treating intracranial aneurysms. Neurochirurgie 58(2–3):61–75. https://doi.org/10.1016/j.neuchi.2012.02.023
doi: 10.1016/j.neuchi.2012.02.023 pubmed: 22483173
Wabl R (2024) On Using the Wrong Tool: Transcranial Doppler to Screen for Large Vessel Vasospasm After Aneurysmal Subarachnoid Hemorrhage. Crit Care Med.  https://doi.org/10.1097/CCM.0000000000006262
Mastantuono J-M, Combescure C, Elia N, Tramèr MR, Lysakowski C (Oct.2018) Transcranial Doppler in the Diagnosis of Cerebral Vasospasm: An Updated Meta-Analysis. Crit Care Med 46(10):1665–1672. https://doi.org/10.1097/CCM.0000000000003297
doi: 10.1097/CCM.0000000000003297 pubmed: 30080684
Hollingworth M, Jamjoom AAB, Bulters D, Patel HC (2019) How is vasospasm screening using transcranial Doppler associated with delayed cerebral ischemia and outcomes in aneurysmal subarachnoid hemorrhage? Acta Neurochir (Wien) 161(2):385–392. https://doi.org/10.1007/s00701-018-3765-8
doi: 10.1007/s00701-018-3765-8 pubmed: 30637487
Kerschbaumer J et al (2023) A randomized, single ascending dose safety, tolerability and pharmacokinetics study of NicaPlant® in aneurysmal subarachnoid hemorrhage patients undergoing clipping. Brain Spine 3:102673. https://doi.org/10.1016/j.bas.2023.102673
doi: 10.1016/j.bas.2023.102673 pubmed: 38021019 pmcid: 10668089
Wessels L et al (2024) Localized Nicardipine Release Implants for Prevention of Vasospasm After Aneurysmal Subarachnoid Hemorrhage: A Randomized Clinical Trial. JAMA Neurol.  https://doi.org/10.1001/jamaneurol.2024.2564

Auteurs

Robert Mertens (R)

Department of Neurosurgery, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Center for Stroke Research Berlin, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Berlin Institute of Health, BIH Academy, Junior Clinician Scientist Program, Charité - Universitätsmedizin Berlin, Berlin, Germany.

Stefan Wolf (S)

Department of Neurosurgery, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Center for Stroke Research Berlin, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.

Lars Wessels (L)

Department of Neurosurgery, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Center for Stroke Research Berlin, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.

Nils Hecht (N)

Department of Neurosurgery, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Center for Stroke Research Berlin, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.

Jens Gempt (J)

Department of Neurosurgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Bernhard Meyer (B)

Department of Neurosurgery, Klinikum rechts der Isar, Technical University Munich, Munich, Germany.

Florian Ringel (F)

Department of Neurosurgery, University Medical Center Mainz, Mainz, Germany.

Veit Rohde (V)

Department of Neurosurgery, University Medical Center Göttingen, Göttingen, Germany.

Peter Vajkoczy (P)

Department of Neurosurgery, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany. peter.vajkoczy@charite.de.
Center for Stroke Research Berlin, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany. peter.vajkoczy@charite.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH